MA58700B1 - Souche de cutibacterium acnes et utilisations médicales associées - Google Patents
Souche de cutibacterium acnes et utilisations médicales associéesInfo
- Publication number
- MA58700B1 MA58700B1 MA58700A MA58700A MA58700B1 MA 58700 B1 MA58700 B1 MA 58700B1 MA 58700 A MA58700 A MA 58700A MA 58700 A MA58700 A MA 58700A MA 58700 B1 MA58700 B1 MA 58700B1
- Authority
- MA
- Morocco
- Prior art keywords
- strain
- medical uses
- cutibacterium acnes
- associated medical
- acnes strain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
- C12N1/066—Lysis of microorganisms by physical processes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
La présente invention concerne une souche bactérienne sélectionnée de Cutibacterium acnes et/ou une paroi cellulaire de celle-ci ou un post-biotique de la souche et des utilisations médicales ou nutritionnelles associées. L'invention concerne également des compositions pharmaceutiques ou nutritionnelles contenant la souche, la paroi cellulaire ou le post-biotique de celle-ci pour la prévention ou le traitement de maladies inflammatoires telles que la dermatite, le psoriasis ou les infections, en particulier les infections fongiques ou bactériennes de la peau ou des muqueuses.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102020000003233A IT202000003233A1 (it) | 2020-02-18 | 2020-02-18 | Ceppo batterico e suoi usi medici |
| EP21711182.2A EP4107293B1 (fr) | 2020-02-18 | 2021-02-18 | Souche de cutibacterium acnes et utilisations médicales associées |
| PCT/EP2021/054083 WO2021165434A1 (fr) | 2020-02-18 | 2021-02-18 | Souche de cutibacterium acnes et utilisations médicales associées |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA58700B1 true MA58700B1 (fr) | 2025-04-30 |
Family
ID=70804885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA58700A MA58700B1 (fr) | 2020-02-18 | 2021-02-18 | Souche de cutibacterium acnes et utilisations médicales associées |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US12508288B2 (fr) |
| EP (1) | EP4107293B1 (fr) |
| JP (1) | JP7832676B2 (fr) |
| KR (1) | KR20220149543A (fr) |
| CN (1) | CN115698258A (fr) |
| AU (1) | AU2021225048A1 (fr) |
| BR (1) | BR112022015153A2 (fr) |
| CA (1) | CA3167099A1 (fr) |
| CO (1) | CO2022013143A2 (fr) |
| ES (1) | ES2983028T3 (fr) |
| HR (1) | HRP20240892T1 (fr) |
| HU (1) | HUE067226T2 (fr) |
| IL (1) | IL295326A (fr) |
| IT (1) | IT202000003233A1 (fr) |
| MA (1) | MA58700B1 (fr) |
| MD (1) | MD4107293T2 (fr) |
| MX (1) | MX2022009744A (fr) |
| PH (1) | PH12022552059A1 (fr) |
| PL (1) | PL4107293T3 (fr) |
| RS (1) | RS65788B1 (fr) |
| SA (1) | SA522440072B1 (fr) |
| SM (1) | SMT202400348T1 (fr) |
| WO (1) | WO2021165434A1 (fr) |
| ZA (1) | ZA202208862B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230392127A1 (en) * | 2020-10-21 | 2023-12-07 | Kangstem Biotech Co., Ltd. | Method for construction of atopic dermatitis model by using pluripotent stem cell-derived skin organoid |
| IT202100013292A1 (it) * | 2021-05-21 | 2022-11-21 | Aileens Pharma S R L | Parete cellulare batterica legata a mucopolisaccaride suoi utilizzi e processo per la sua produzione |
| JP7789199B2 (ja) * | 2021-10-27 | 2025-12-19 | シージェイ バイオサイエンス， インク． | キューティバクテリウム属菌株を含む炎症性皮膚疾患の予防、または改善用化粧料組成物 |
| US20250228901A1 (en) * | 2021-10-27 | 2025-07-17 | Cj Bioscience, Inc. | Composition for preventing, alleviating or treating inflammatory skin diseases, comprising cutibacterium sp. strain |
| GB2623078B (en) * | 2022-10-03 | 2025-04-16 | Univ Brunel | Prevention and/or treatment of wound infection |
| WO2024165954A1 (fr) * | 2023-02-06 | 2024-08-15 | Johnson & Johnson Consumer Inc. | Compositions biomimétiques, prébiotiques, probiotiques et postbiotiques de cutibacterium acnes pour le traitement d'affections cutanées |
| CN117165489B (zh) * | 2023-09-21 | 2024-04-19 | 山东福瑞达生物股份有限公司 | 一种痤疮丙酸杆菌发酵上清液、制备方法及其应用 |
| EP4559469A1 (fr) | 2023-11-22 | 2025-05-28 | Aileens Pharma S.r.l. | Compositiones pour le traitement ou la prévention d'une dysbiose |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3580453B2 (ja) * | 1995-09-28 | 2004-10-20 | 株式会社アドバンス | 細胞賦活性化粧料 |
| WO2015106175A1 (fr) * | 2014-01-10 | 2015-07-16 | The Regents Of The University Of California | Probiotique pour la peau |
-
2020
- 2020-02-18 IT IT102020000003233A patent/IT202000003233A1/it unknown
-
2021
- 2021-02-18 US US17/798,420 patent/US12508288B2/en active Active
- 2021-02-18 ES ES21711182T patent/ES2983028T3/es active Active
- 2021-02-18 SM SM20240348T patent/SMT202400348T1/it unknown
- 2021-02-18 PL PL21711182.2T patent/PL4107293T3/pl unknown
- 2021-02-18 AU AU2021225048A patent/AU2021225048A1/en active Pending
- 2021-02-18 MD MDE20221416T patent/MD4107293T2/ro unknown
- 2021-02-18 CN CN202180029037.5A patent/CN115698258A/zh active Pending
- 2021-02-18 PH PH1/2022/552059A patent/PH12022552059A1/en unknown
- 2021-02-18 JP JP2022548530A patent/JP7832676B2/ja active Active
- 2021-02-18 WO PCT/EP2021/054083 patent/WO2021165434A1/fr not_active Ceased
- 2021-02-18 CA CA3167099A patent/CA3167099A1/fr active Pending
- 2021-02-18 BR BR112022015153A patent/BR112022015153A2/pt unknown
- 2021-02-18 IL IL295326A patent/IL295326A/en unknown
- 2021-02-18 MX MX2022009744A patent/MX2022009744A/es unknown
- 2021-02-18 MA MA58700A patent/MA58700B1/fr unknown
- 2021-02-18 EP EP21711182.2A patent/EP4107293B1/fr active Active
- 2021-02-18 HR HRP20240892TT patent/HRP20240892T1/hr unknown
- 2021-02-18 KR KR1020227031999A patent/KR20220149543A/ko active Pending
- 2021-02-18 RS RS20240699A patent/RS65788B1/sr unknown
- 2021-02-18 HU HUE21711182A patent/HUE067226T2/hu unknown
-
2022
- 2022-08-07 SA SA522440072A patent/SA522440072B1/ar unknown
- 2022-08-08 ZA ZA2022/08862A patent/ZA202208862B/en unknown
- 2022-09-15 CO CONC2022/0013143A patent/CO2022013143A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4107293C0 (fr) | 2024-04-24 |
| RS65788B1 (sr) | 2024-08-30 |
| SMT202400348T1 (it) | 2024-11-15 |
| JP2023518665A (ja) | 2023-05-08 |
| PH12022552059A1 (en) | 2024-02-12 |
| WO2021165434A1 (fr) | 2021-08-26 |
| CO2022013143A2 (es) | 2022-12-09 |
| AU2021225048A1 (en) | 2022-09-01 |
| BR112022015153A2 (pt) | 2022-10-11 |
| SA522440072B1 (ar) | 2023-11-19 |
| ES2983028T3 (es) | 2024-10-21 |
| IL295326A (en) | 2022-10-01 |
| HUE067226T2 (hu) | 2024-10-28 |
| ZA202208862B (en) | 2023-12-20 |
| CA3167099A1 (fr) | 2021-08-26 |
| EP4107293B1 (fr) | 2024-04-24 |
| KR20220149543A (ko) | 2022-11-08 |
| CN115698258A (zh) | 2023-02-03 |
| IT202000003233A1 (it) | 2021-08-18 |
| JP7832676B2 (ja) | 2026-03-18 |
| EP4107293A1 (fr) | 2022-12-28 |
| US20240024375A1 (en) | 2024-01-25 |
| MX2022009744A (es) | 2022-11-09 |
| MD4107293T2 (ro) | 2024-09-30 |
| PL4107293T3 (pl) | 2024-09-30 |
| US12508288B2 (en) | 2025-12-30 |
| HRP20240892T1 (hr) | 2024-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA58700B1 (fr) | Souche de cutibacterium acnes et utilisations médicales associées | |
| MA64509B1 (fr) | Composés hétérocycliques utilisés comme immunomodulateurs | |
| MA64121B1 (fr) | Composés hétérocycliques utilisés comme immunomodulateurs | |
| JOP20220179A1 (ar) | N4-هيدروكسي سيتيدين ومشتقات واستخدامات مضادة للفيروسات مرتبطة بها | |
| TN2010000239A1 (fr) | Composition pour l'alimentation humaine et/ou animale ses utilisations, levures | |
| MA29713B1 (fr) | Derives de tetrahydroindolone et de tetrahydroindazolone | |
| MA27311A1 (fr) | Utilisation d'inhibiteurs de cetp et facultativement d'inhibiteurs de hmg-coa-reductase et/ou d'agents antihypertensifs | |
| MA30333B1 (fr) | Aminotetrahydropyranes utiles en tant qu'inhibiteurs de la dipeptidyle peptidase-iv pour le traitement ou la prevention du diabete. | |
| MA44674A (fr) | Inhibiteurs de bromodomaine | |
| MA44851B1 (fr) | Dérivés pyridinyltriazole substitués par des groupements amides et leurs utilisations | |
| HU9301550D0 (en) | New hydroxamine acid and n-hydroxy-carbamide derivatives and their applications | |
| PT746327E (pt) | Nitrito acidificado como um agente antimicrobiano | |
| MA27794A1 (fr) | Dihydroquinazolines substituees a proprietes antivirales | |
| AU4310097A (en) | Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists | |
| MA31902B1 (fr) | Oxazolidinones pour le traitement et/ou la prophylaxie de l'insuffisance cardiaque | |
| Sakko et al. | Antimicrobial 2‐hydroxyisocaproic acid and chlorhexidine resist inactivation by dentine | |
| FR3065009B1 (fr) | Secretome bacterien pour son utilisation dans le traitement des lesions cutanees | |
| MA31562B1 (fr) | Macrocycles et leurs utilisations | |
| BR0313589A (pt) | Uso de extrato de germe de trigo fermentado como agente antiinflamatório | |
| Emira et al. | In vitro activity of Melaleuca alternifolia (Tea tree) and Eucalyptus globulus essential oils on oral Candida biofilm formation on polymethylmethacrylate | |
| WO2004000372A3 (fr) | Composition desinfectante, comprimes de nettoyage produits a partir de cette composition et leur utilisation | |
| MA54276B1 (fr) | Montélukast destinée au traitement de l'arthrose de la main | |
| FR3076711B1 (fr) | Composition comprenant l'hydroxychloroquine et utilisation therapeutique | |
| WO2022254446A1 (fr) | Méthode destinée au traitement d'une croissance microbienne excessive, d'un déséquilibre et d'infections | |
| EP4205737A4 (fr) | Composition pour la prévention, l'amélioration ou le traitement de maladies inflammatoires ou de maladies immunitaires comprenant la gancaonine n en tant que principe actif |